Angelini Labopharm Announces The U.S. Launch Of OLEPTRO™ For The Treatment Of Major Depressive Disorder In Adults
Links shared publicly online about this topic.
- 944total visits
Angelini Labopharm Announces The U.S. Launch Of OLEPTRO™ For The Treatment Of Major Depressive Disorder In Adults
View full resource at medicalnewstoday.com
Tags: Pain Medication, Depression, Antidepressant, Major Depression, Disease and Condition, Desyrel
Most Recently Shared on August 16, 2010 at 4:54 pm By:
Angelini Labopharm Announces The U.S. Launch Of OLEPTRO For The Treatment Of Major Depressive Disorder In Adults: ... http://mnt.to/f/3HpG
Also Shared By:
Labopharm Announces Elimination of Angelini Labopharm's Oleptro Sales Force - Drugs.com MedNews
drugs.com — “OLEPTRO to Continue to be Available in U.S. Market LAVAL, QC, Aug. 17, 2011 CNW - Labopharm Inc. (TSX DDS) announced today that Angelini Labopharm, LLC, the Com” View full resource at drugs.com
Most Recently Shared on August 18, 2011 at 2:15 pm By:
Drugs and Devices OW OW Health
Labopharm Announces Elimination of Angelini Labopharm's Oleptro Sales Force: OLEPTRO™ to Continue to be Av... http://t.co/Un3pcE2 #drug
Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.
news-medical.net — “Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation o” View full resource at news-medical.net
Most Recently Shared on August 11, 2010 at 10:45 am By:
Pregnancy News: Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.: Labopharm Inc. to... http://bit.ly/9JufSO
Angelini Labopharm Announces the U.S. Launch of OLEPTRO(TM) for the Treatment of Major Depressive Disorder in Adults - Health News - redOrbit
redorbit.com — “PRINCETON, N.J., Aug. 10 /PRNewswire/ -- Angelini Labopharm today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, is now commercially available in the United States.” View full resource at redorbit.com
Most Recently Shared on August 10, 2010 at 5:11 pm By:
Angelini Labopharm Announces the U.S. Launch of OLEPTRO(TM) for the Treatment of Major Depressive Disorder in Adul... http://bit.ly/9DMSCm
Oleptro available for major depressive disorder - MPR
empr.com — “Labopharm and Angelini announced the launch of Oleptro (trazodone HCl extended-release tablets) for the treatment of major depressive disorder (MDD) in adults.” View full resource at empr.com
Most Recently Shared on August 10, 2010 at 3:33 pm By:
MPR News: Oleptro available for major depressive disorder: Labopharm and Angelini announced the launch of Oleptro ... http://bit.ly/9xoFSv
Oleptro available for major depressive disorder - ONA
oncologynurseadvisor.com — “Labopharm and Angelini announced the launch of Oleptro (trazodone HCl extended-release tablets) for the treatment of major depressive disorder (MDD) in adults.” View full resource at oncologynurseadvisor.com
Most Recently Shared on August 10, 2010 at 3:11 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Oleptro available for major depressive disorder http://goo.gl/fb/AJO0T
Advertisement
Peter H Brown
@PeterBrownPsy
Angelini Labopharm Announces The U.S. Launch Of OLEPTRO™ For The Treatment Of Major Depressive Dis.. http://mnt.to/f/3HpG #depression
1 year ago...